Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Dublin, OH
SEC filing record 1 source field available
Fiscal year end
31 December
NAVIDEA BIOPHARMACEUTICALS, INC. has filed 1,465 SEC EDGAR filings since 07 Feb 1995

SEC filing history

Showing 1-15 of 15 matching filings.

Per page
25
Current page
1
10-K File 001-35076

NAVIDEA BIOPHARMACEUTICALS FORM 10-K

Filing date
31 Mar 2017
Reporting date
31 Dec 2016
Next action
Verify source filing
10-K/A File 001-35076

FORM 10-K/A

Filing date
21 Mar 2013
Reporting date
31 Dec 2012
Next action
Verify source filing
10-K File 001-35076

FORM 10-K

Filing date
18 Mar 2013
Reporting date
31 Dec 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 001-35076

10-K filing

Filing date
16 Mar 2011
Reporting date
31 Dec 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 000-26520

10-K filing

Filing date
31 Mar 2010
Reporting date
31 Dec 2009
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .